life science companies that transform the lives of patients worldwide
Improving patients lives
(Nasdaq: AUPH, TSX: AUP)
life science companies that transform the lives of patients worldwide
Acquired by UCB
life science companies that transform the lives of patients worldwide
Building Better Biologics
(NYSE: ZYME)
Acquired by Gilead Sciences
$11.2B
life science companies that transform the lives of patients worldwide
life science companies that transform the lives of patients worldwide
The immune system preserved
(Nasdaq: GTHX)
ICIZED.
Acquired by Stryker
$1.65B
life science companies that transform the lives of patients worldwide
Severe Asthma
FORMED.
Acquired by Cephalon
$550 million
life science companies that transform the lives of patients worldwide
Lumira Ventures partners with exceptional entrepreneurs to build life science companies that transform the lives of patients worldwide.
Trending
2021 CVCA Awards: Lumira Ventures winner of 2021 VC Regional Impact Award for Western Canada for Zymeworks
June 4, 2021
Lumira Ventures prides itself on being a VC investor that backs promising early-stage health care and life sciences companies with the potential to dramatically improve patient care. It was with... Learn More
Lumira Ventures is pleased to participate in the $92 million Series E financing for BioTheryX
May 20, 2021
BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving cancer medicines, today announced a $92 million Series E financing led by Farallon Capital... Learn More
The Lumira Ventures Venture Innovation Program
April 28, 2021
With the establishment of Lumira Ventures Fund IV, the largest life sciences focused venture fund ever raised in Canada, we launched our Lumira Ventures Venture Innovation Program (Lumira... Learn More
Lumira portfolio company Antios Therapeutics raises $96 Million in a Series B financing
April 12, 2021
Antios Therapeutics, Inc. (“Antios”) today announced the successful completion of a $96 million Series B financing. The proceeds from this financing will support the ongoing Phase 2 clinical... Learn More
Team Lumira
Our investment team of 12 professionals has over 225 years of collective experience founding, managing and investing in healthcare and life sciences companies. We value collaboration, creativity and challenging conventional wisdom.
Philanthropy
Lumira donates a portion of partner time and profits to support the research, translational medicine and healthcare access missions of over a dozen leading healthcare foundations.
Contact Us
Our team is strategically situated across North America to identify innovative companies within and outside the traditional start-up hubs, and help them access capital, talent and strategic partners.
Toronto
141 Adelaide Street
Suite 770
Toronto, ON
Canada, M5H 3L5
416.213.4223
Montreal
Espace CDPQ
3, Place Ville Marie
Bureau 12350, Niveau L
Montreal, QC
Canada, H3B 0E7
514.844.6927
Vancouver
1021 West Hastings Street,
9th floor
Vancouver, BC
Canada, V6E 0C3
604.558.5156
Boston
303 Wyman Street
Suite 300
Waltham, MA,
USA, 02451-1208
781.530.3868